Last reviewed · How we verify
NCT04497428
Sensory Basis of Speech Motor Learning
NA trial testing Adaptation in Speech in 160 participants. Terminated before completion.
31 July 2025
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 160 |
| Start date | 1 August 2019 |
| Primary completion | 31 July 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Adaptation
- cTBS
Conditions studied
- Speech — all drugs for Speech →
- Consolidation — all drugs for Consolidation →
Sponsor
Yale University
Who can join
Adults 21 to 40, any sex, with Speech or Consolidation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
These studies test the hypothesis that sensory areas of the brain participate in the consolidation of speech motor memory by using transcranial magnetic stimulation to suppress activity in somatosensory and auditory cortex following adaptation in order to block retention of learning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04497428
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Adaptation
Trials testing the same drug.
- NCT06467305 — Speech Motor Learning and Retention (Aim 1) · NA · recruiting
- NCT06467292 — Speech Motor Learning and Retention (Master Protocol) · NA · recruiting
- NCT06491823 — Speech Motor Learning and Retention (Aim 2) · NA · recruiting
- NCT04818021 — Contribution of the Somatosensory System to Speech Perceptual Processing · NA · terminated
- NCT04818268 — Sensory Memory in Speech Motor Learning · NA · terminated
Other recruiting trials for Speech
Currently open trials in the same condition.
- NCT06479278 — Talk With Me Baby to Enhance the Early Home Language Environment · NA · recruiting
- NCT06467292 — Speech Motor Learning and Retention (Master Protocol) · NA · recruiting
- NCT06491823 — Speech Motor Learning and Retention (Aim 2) · NA · recruiting
- NCT06467305 — Speech Motor Learning and Retention (Aim 1) · NA · recruiting
- NCT06589570 — Intelligibility and Acoustic Speech Performance of CAD/CAM Milled Titanium Partial Dentures · NA · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04497428 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 11 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04497428.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing